Lactobacillus paracasei continuous ambulatory peritoneal dialysis-related peritonitis and review of the literature.
We describe the first case of continuous ambulatory peritoneal dialysis (CAPD)-related peritonitis due to Lactobacillus paracasei. It occurred in a 65-year-old patient with recurrent episodes of peritonitis while he was receiving a prolonged course of intraperitoneal vancomycin. L. paracasei should be considered in the differential diagnosis of pathogens in CAPD-related peritonitis, especially in patients receiving prolonged vancomycin or glycopeptide treatment.
Neef
Phyllis A
PA
Dayton Veterans Affairs Medical Center, Wright State University School of Medicine, Dayton, Ohio 45428, USA.
Polenakovik
Hari
H
Clarridge
Jill E
JE
Saklayen
Mohammad
M
Bogard
Laura
L
Bernstein
Jack M
JM
D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D007778:Lactobacillus / Q000302:isolation & purification; D008297:Male; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy / Q000382:microbiology*; D014640:Vancomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D014640:Vancomycin